Heron Therapeutics Inc
HRTX
Market Cap$335.64M
Close$
$3.67
66.8% upside
Current Fair Value
66.8% upsideUndervalued by 66.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $335.64 Million |
|---|---|
| Enterprise Value | $493.63 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.09 |
| Beta | 1.17 |
| Outstanding Shares | 153,490,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -43.38 |
|---|---|
| PEG | 23.65 |
| Price to Sales | 2.2 |
| Price to Book Ratio | -2.2 |
| Enterprise Value to Revenue | 3.12 |
| Enterprise Value to EBIT | -154.07 |
| Enterprise Value to Net Income | -64 |
| Total Debt to Enterprise | 0.36 |
| Debt to Equity | -6.23 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Heron Therapeutics Inc
CEO: Barry Quart